Farid Bagheri

Dr. Farid Bagheri

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2024 in Jundishapur Journal of Natural Pharmaceutical Products
Verified
Journal Article
Open access
PDF file
HKHossein Heidari kaydan
Hossein Heidari kaydan
BMBehzad Sharif Makhmlzadeh
Behzad Sharif Makhmlzadeh
MFMostafa Feghhi
Mostafa Feghhi
ARAnahita Rezaei
Anahita Rezaei
FBFarid Bagheri
Farid Bagheri
ASAnayatollah Salimi
Anayatollah Salimi
Background: Limitations in drug penetration are overcome by nanotechnology, particularly liposomes, which enhance targeted administration of ocular medications. Liposomes can augment the therapeutic effects of curcumin, a natural compound with positive impacts on the retina. Treatments for eye diseases can also benefit from the antibacterial properties of ozonated oil liposomes. Objectives: This study aims to develop and evaluate ozonated liposomes loaded with curcumin for ocular drug delivery applications, specifically targeting diabetic retinopathy (DR). Methods: Liposomal nanoparticles were prepared using thin-film hydration, incorporating phospholipids, lecithin, cholesterol, ozonated oil, and curcumin. We assessed physicochemical properties including particle size, zeta potential, encapsulation efficiency (EE), and morphology. Drug release profiles and stability studies were also conducted. Results: The optimized liposomes showed a particle size of 84.77 nm, a zeta potential of -16.8 mV, and an EE of 94.73%. The formulation exhibited sustained curcumin release over 24 hours, reaching 82.09% cumulative release. Stability studies indicated minimal changes in key parameters over three months at room temperature. Conclusions: The developed ozonated liposomal formulation demonstrates promising characteristics for curcumin delivery, potentially enhancing its therapeutic efficacy in ocular applications, particularly for DR.

20 November 2022 in Iranian Biomedical Journal
Verified
Journal Article
Open access
PDF file
ASAnayatollah Salimi
Anayatollah Salimi
SASara Amirimoghadam
Sara Amirimoghadam
FBFarid Bagheri
Farid Bagheri
Background: Flavonoids are a large group of phenolic compounds possessing anti-inflammatory and antioxidant effects. NAR is a flavonoid with various pharmacological properties. Using pharmaceutical compounds on skin is one of the routes of administration to achieve local and systemic effects. The aim of this study was to develop a topical formulation of NAR ...

10 August 2026 in Jundishapur Journal of Natural Pharmaceutical Products
Verified
Journal Article
Open access
PDF file
ZBZahra Bahaeddin
Zahra Bahaeddin
ZSZahra SabetNejad
Zahra SabetNejad
KTKowsar Naseri Taheri
Kowsar Naseri Taheri
FBFarid Bagheri
Farid Bagheri
HKHossein Heidari kaydan
Hossein Heidari kaydan
ANAmin Noori
Amin Noori
Context: Buprenorphine and methadone maintenance therapy are widely used for opioid use disorder; however, their limitations have prompted investigation into alternative approaches. Because medicinal plants may act on multiple pharmacological targets, they have emerged as potential therapeutic candidates. This systematic review assessed preclinical evidence from studies conducted in Iran regarding the efficacy of Iranian medicinal plants in alleviating morphine withdrawal symptoms. Evidence Acquisition: A comprehensive literature search was conducted in IranMedex, PubMed, Scopus, Google Scholar, MagIran, and SID through April 2026. We included preclinical animal studies conducted in Iran that investigated the effects of Iranian medicinal plants on morphine withdrawal syndrome. Eligible studies published in Persian or English were screened in accordance with PRISMA guidelines. Results: Twenty-seven studies were eligible and reported 27 medicinal plants that reduced withdrawal symptoms, including jumping, diarrhea, weight loss, locomotor alterations, tremor, teeth chattering, and wet-dog shakes. Most plants reduced multiple withdrawal signs, and a few produced effects comparable to those of reference drugs. Proposed mechanisms involved dopaminergic, GABAergic, serotonergic, and inflammatory pathways. Discussion: Iranian preclinical evidence suggests that medicinal plants may help alleviate morphine withdrawal syndrome. However, because clinical evidence is lacking, standardized experimental studies, dose-response evaluations, safety assessments, and well-designed clinical trials are needed to establish therapeutic efficacy and clinical translatability.